FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jacob Canick

Research Profile

Physiology

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Anatomy

Chromosomes, Human, Pair 18

Co-author Network

Publications

TOP 3
Amin R Mazloom; Ron McCullough; Graham McLennan; Wendy Meschino; Paul Oeth; Glenn E Palomaki; Juan-Sebastian Saldivar; John Tynan; Dirk van den Boom; Huiquan Wang; Zeljko Džakula; Mathias Ehrich; Taylor Jensen; Margo Maeder; Allan T Bombard; Jacob A Canick; Cosmin Deciu
Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma.
James E Haddow; Geralyn Lambert-Messerlian; Fergal D Malone; Louis M Neveux; Glenn E Palomaki; Mary E D'Alton; Jacob A Canick; Wendy Y Craig
Impact of adjusting for the reciprocal relationship between maternal weight and free thyroxine during early pregnancy.
Taylor J Jensen; Sung K Kim; Tim Lu; Amin R Mazloom; Graham McLennan; Paul Oeth; Glenn E Palomaki; Roger C Tim; John Tynan; Dirk van den Boom; Zhanyang Zhu; Tricia Zwiefelhofer; Željko Džakula; Jacob A Canick; Cosmin Deciu; Mathias Ehrich
High-throughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jacob Canick (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Amin R Mazloom; Ron McCullough; Graham McLennan; Wendy Meschino; Paul Oeth; Glenn E Palomaki; Juan-Sebastian Saldivar; John Tynan; Dirk van den Boom; Huiquan Wang; Zeljko Džakula; Mathias Ehrich; Taylor Jensen; Margo Maeder; Allan T Bombard; Jacob A Canick; Cosmin Deciu
Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma.
Prenatal diagnosis 2013;33(6):591-7.
2013: James E Haddow; Geralyn Lambert-Messerlian; Fergal D Malone; Louis M Neveux; Glenn E Palomaki; Mary E D'Alton; Jacob A Canick; Wendy Y Craig
Impact of adjusting for the reciprocal relationship between maternal weight and free thyroxine during early pregnancy.
Thyroid : official journal of the American Thyroid Association 2013;23(2):225-30.
2013: Taylor J Jensen; Sung K Kim; Tim Lu; Amin R Mazloom; Graham McLennan; Paul Oeth; Glenn E Palomaki; Roger C Tim; John Tynan; Dirk van den Boom; Zhanyang Zhu; Tricia Zwiefelhofer; Željko Džakula; Jacob A Canick; Cosmin Deciu; Mathias Ehrich
High-throughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma.
PloS one 2013;8(3):e57381.
2012: Jacob A Canick; Cosmin Deciu; Mathias Ehrich; James E Haddow; Edward M Kloza; Geralyn M Lambert-Messerlian; Allan T Bombard; Dirk van den Boom; Glenn E Palomaki
DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations.
Prenatal diagnosis 2012;32(8):730-4.
2012: Jacob A Canick; Glenn E Palomaki
Maternal plasma DNA: a major step forward in prenatal testing.
Journal of medical screening 2012;19(2):57-9.
2012: Glenn E Palomaki; Dirk van den Boom; Allan T Bombard; Cosmin Deciu; Mathias Ehrich; Wayne W Grody; James E Haddow; Edward M Kloza; Geralyn M Lambert-Messerlian; Stanley F Nelson; Louis M Neveux; Jacob A Canick
DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study.
Genetics in medicine : official journal of the American College of Medical Genetics 2012;14(3):296-305.
2012: Geralyn M Lambert-Messerlian; Louis M Neveux; Glenn E Palomaki; Maureen G Phipps; Elizabeth E Eklund; Edward M Kloza; Jacob A Canick
Feasibility of using plasma rather than serum in first and second trimester multiple marker Down's syndrome screening.
Journal of medical screening 2012;19(4):164-70.
2011: James E Haddow; Geralyn Lambert-Messerlian; Jacob A Canick; David Grenache; Louis M Neveux; Glenn E Palomaki; Jun Lu
The relationship between PTH and 25-hydroxy vitamin D early in pregnancy.
Clinical endocrinology 2011;75(3):309-14.
2011: Jing Zhang; Geralyn M Lambert-Messerlian; Glenn E Palomaki; Jacob A Canick
Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters.
Prenatal diagnosis 2011;31(6):583-8.
2011: Nicole M Sprawka; Geralyn M Lambert-Messerlian; Glenn E Palomaki; Elizabeth E Eklund; Jacob A Canick
Adjustment of maternal serum alpha-fetoprotein levels in women with pregestational diabetes.
Prenatal diagnosis 2011;31(3):282-5.
2011: James E Haddow; Monica R McClain; Glenn E Palomaki; Louis M Neveux; Geralyn M Lambert-Messerlian; Jacob A Canick; Fergal D Malone; T Flint Porter; David A Nyberg; Peter S Bernstein; Mary E D'alton
Thyroperoxidase and thyroglobulin antibodies in early pregnancy and placental abruption.
Obstetrics and gynecology 2011;117(2 Pt 1):287-92.
2010: Glenn E Palomaki; George J Knight; Geralyn Lambert-Messerlian; Jacob A Canick; James E Haddow
Four years' experience with an interlaboratory comparison program involving first-trimester markers of Down syndrome.
Archives of pathology & laboratory medicine 2010;134(11):1685-91.
2010: James E Haddow; Jane Cleary-Goldman; Monica R McClain; Glenn E Palomaki; Louis M Neveux; Geralyn M Lambert-Messerlian; Jacob A Canick; Fergal D Malone; T Flint Porter; David A Nyberg; Peter S Bernstein; Mary E D'alton
Thyroperoxidase and thyroglobulin antibodies in early pregnancy and preterm delivery.
Obstetrics and gynecology 2010;116(1):58-62.
2010: Geralyn Lambert-Messerlian; Glenn E Palomaki; Jacob A Canick
Examination of the pregnancy-associated plasma protein-A assay on the Beckman Coulter Access(®) platform: suitability for use in first trimester Down's syndrome screening.
Journal of medical screening 2010;17(3):109-13.
2009: Geralyn M Lambert-Messerlian; Glenn E Palomaki; Louis M Neveux; Edward Chien; Alex Friedman; Karen Rosene-Montella; Meghan Hayes; Jacob A Canick
Early onset preeclampsia and second trimester serum markers.
Prenatal diagnosis 2009;29(12):1109-17.
2009: Glenn E Palomaki; Jo Ellen S Lee; Jacob A Canick; Geraldine A McDowell; Alan E Donnenfeld
Technical standards and guidelines: prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurements.
Genetics in medicine : official journal of the American College of Medical Genetics 2009;11(9):669-81.
2009: Mary E D'alton; Jane Cleary-Goldman; Geralyn M Lambert-Messerlian; Robert Ball; David A Nyberg; Christine H Comstock; Radek Bukowski; Richard L Berkowitz; Pe'er Dar; Lorraine Dugoff; Sabrina D Craigo; I E Timor; Stephen R Carr; Honor M Wolfe; Kim Dukes; Jacob A Canick; Fergal D Malone
Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2009;33(2):142-6.
2009: Geralyn Lambert-Messerlian; Glenn E Palomaki; Jacob A Canick
Adjustment of serum markers in first trimester screening.
Journal of medical screening 2009;16(2):102-3.
2008: James E Haddow; Monica R McClain; Geralyn M Lambert-Messerlian; Glenn E Palomaki; Jacob A Canick; Jane Cleary-Goldman; Fergal D Malone; T Flint Porter; David A Nyberg; Peter S Bernstein; Mary E D'alton
Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy.
The Journal of clinical endocrinology and metabolism 2008;93(9):3341-7.
2008: Nicholas J Wald; Jonathan P Bestwick; Jacob A Canick
Contingent screening for Down syndrome.
Prenatal diagnosis 2008;28(8):781; author reply 782.
2008: Monica R McClain; Geralyn M Lambert-Messerlian; James E Haddow; Glenn E Palomaki; Jacob A Canick; Jane Cleary-Goldman; Fergal D Malone; T Flint Porter; David A Nyberg; Peter S Bernstein; Mary E D'alton
Sequential first- and second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study.
American journal of obstetrics and gynecology 2008;199(2):129.e1-6.
2008: Geralyn M Lambert-Messerlian; Monica McClain; James E Haddow; Glenn E Palomaki; Jacob A Canick; Jane Cleary-Goldman; Fergal D Malone; T Flint Porter; David A Nyberg; Peter S Bernstein; Mary E D'alton
First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study.
American journal of obstetrics and gynecology 2008;199(1):62.e1-6.
2008: Geralyn M Lambert-Messerlian; Glenn E Palomaki; Jacob A Canick
Inhibin A measurement using an automated assay platform.
Prenatal diagnosis 2008;28(5):399-403.
2008: Beth J Plante; Jeffrey D Blume; Geralyn M Lambert-Messerlian; Rebecca Shackelton; Jacob A Canick; Maureen G Phipps
A multiple marker model to predict pregnancy viability when progesterone is indeterminate.
The Journal of reproductive medicine 2008;53(4):243-9.
2008: Devereux N Saller; Jacob A Canick
Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
Clinical obstetrics and gynecology 2008;51(1):24-36.
2008: Adam C Urato; Inga Peter; Jacob A Canick; Geralyn M Lambert-Messerlian; Andrea Pulkkinen; George Knight; Young-Ju Jeong; Kirby L Johnson; Diana Bianchi
Smoking in pregnancy is associated with increased total maternal serum cell-free DNA levels.
Prenatal diagnosis 2008;28(3):186-90.
2008: Glenn E Palomaki; Louis M Neveux; Alan Donnenfeld; Jo Ellen S Lee; Geraldine McDowell; Jacob A Canick; Anne Summers; Geralyn M Lambert-Messerlian; Leonard H Kellner; Arthur Zebelman; James E Haddow
Quality assessment of routine nuchal translucency measurements: a North American laboratory perspective.
Genetics in medicine : official journal of the American College of Medical Genetics 2008;10(2):131-8.
2007: Geralyn M Lambert-Messerlian; Christina Bandera; Elizabeth Eklund; Andrew Neuhauser; Jacob A Canick
Very high inhibin A concentration attributed to heterophilic antibody interference.
Clinical chemistry 2007;53(4):800-1.
2007: Srinivasa R Nagalla; Jacob A Canick; Thomas Jacob; Kimberly A Schneider; Ashok Reddy; Thomas Jacob; Surendra Dasari; Xinfang Lu; Jodi A Lapidus; Geralyn M Lambert-Messerlian; Michael G Gravett; Charles T Roberts; David A Luthy; Fergal D Malone; Mary E D'alton
Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers.
Journal of proteome research 2007;6(4):1245-57.
2007: Glenn E Palomaki; Geralyn M Lambert-Messerlian; Jacob A Canick
A summary analysis of Down syndrome markers in the late first trimester.
Advances in clinical chemistry 2007;43():177-210.
2006: Jacob A Canick; Geralyn M Lambert-Messerlian; Glenn E Palomaki; Louis M Neveux; Fergal D Malone; Robert Ball; David A Nyberg; Christine H Comstock; Radek Bukowski; George R Saade; Richard L Berkowitz; Pe'er Dar; Lorraine Dugoff; Sabrina D Craigo; Ilan E Timor-Tritsch; Stephen R Carr; Honor M Wolfe; Mary E D'alton
Comparison of serum markers in first-trimester down syndrome screening.
Obstetrics and gynecology 2006;108(5):1192-9.
2006: Geralyn M Lambert-Messerlian; Lorraine Dugoff; John Vidaver; Jacob A Canick; Fergal D Malone; Robert Ball; Christine H Comstock; David A Nyberg; George R Saade; Keith A Eddleman; Susan Klugman; Sabrina D Craigo; Ilan E Timor-Tritsch; Stephen R Carr; Honor M Wolfe; Mary E D'alton
First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study.
Prenatal diagnosis 2006;26(8):672-8.
2006: Antonio Farina; Geralyn M Lambert-Messerlian; Jacob A Canick; Irina Banzola; Angela Carletti; Manuela Concu; Annalisa Tempesta; Sandro Gabrielli; Danila Morano; Nicola Rizzo
Total activin A in maternal blood as a marker of preterm delivery in low-risk asymptomatic patients.
Prenatal diagnosis 2006;26(3):277-81.
2006: Geralyn M Lambert-Messerlian; Elizabeth Eklund; Fergal D Malone; Glenn E Palomaki; Jacob A Canick; Mary E D'alton
Stability of first- and second-trimester serum markers after storage and shipment.
Prenatal diagnosis 2006;26(1):17-21.
2005: Fergal D Malone; Jacob A Canick; Robert Ball; David A Nyberg; Christine H Comstock; Radek Bukowski; Richard L Berkowitz; Susan J Gross; Lorraine Dugoff; Sabrina D Craigo; Ilan E Timor-Tritsch; Stephen R Carr; Honor M Wolfe; Kim Dukes; Diana Bianchi; Alicja R Rudnicka; Allan K Hackshaw; Geralyn M Lambert-Messerlian; Nicholas J Wald; Mary E D'alton
First-trimester or second-trimester screening, or both, for Down's syndrome.
The New England journal of medicine 2005;353(19):2001-11.
2005: Phillip D Pan; Inga Peter; Geralyn M Lambert-Messerlian; Jacob A Canick; Diana Bianchi; Kirby L Johnson
Cell-free fetal DNA levels in pregnancies conceived by IVF.
Human reproduction (Oxford, England) 2005;20(11):3152-6.
2005: Geralyn M Lambert-Messerlian; David F Keren; Constantine S Raphtis; Krista Byberg; Jacob A Canick
Apparently low maternal serum inhibin A levels in second-trimester screening.
Prenatal diagnosis 2005;25(10):967-8.
2005: Jacob A Canick; Andrew R MacRae
Second trimester serum markers.
Seminars in perinatology 2005;29(4):203-8.
2005: Fergal D Malone; Robert Ball; David A Nyberg; Christine H Comstock; George R Saade; Richard L Berkowitz; Susan J Gross; Lorraine Dugoff; Sabrina D Craigo; Ilan E Timor-Tritsch; Stephen R Carr; Honor M Wolfe; Kim Dukes; Jacob A Canick; Diana Bianchi; Mary E D'alton
First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome.
Obstetrics and gynecology 2005;106(2):288-94.
2005: Lorraine Dugoff; John C Hobbins; Fergal D Malone; John Vidaver; Lisa Sullivan; Jacob A Canick; Geralyn M Lambert-Messerlian; T Flint Porter; David A Luthy; Christine H Comstock; George R Saade; Keith A Eddleman; Irwin R Merkatz; Sabrina D Craigo; Ilan E Timor-Tritsch; Stephen R Carr; Honor M Wolfe; Mary E D'alton
Quad screen as a predictor of adverse pregnancy outcome.
Obstetrics and gynecology 2005;106(2):260-7.
2005: Geralyn M Lambert-Messerlian; Halit Pinar; Lewis P Rubin; Monique E De Paepe; Umadevi Tantravahi; Margaret M Steinhoff; Michelle Russell; Jacob A Canick
Second-trimester maternal serum markers in twin pregnancy with complete mole: report of 2 cases.
Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2005;8(2):230-4.
2004: Geralyn M Lambert-Messerlian; Jacob A Canick
Placenta growth factor levels in second-trimester maternal serum in Down syndrome pregnancy and in the prediction of preeclampsia.
Prenatal diagnosis 2004;24(11):876-80.
2004: Geralyn M Lambert-Messerlian; Halit Pinar; E Laprade; Umadevi Tantravahi; Alan L Schneyer; Jacob A Canick
Inhibins and activins in human fetal abnormalities.
Molecular and cellular endocrinology 2004;225(1-2):101-8.
2004: Geralyn M Lambert-Messerlian; Jacob A Canick
Clinical application of inhibin a measurement: prenatal serum screening for Down syndrome.
Seminars in reproductive medicine 2004;22(3):235-42.
2004: P Florio; Geralyn M Lambert-Messerlian; Filiberto M Severi; G Buonocore; Jacob A Canick; Felice Petraglia
Fetal neural tube defects: maternal serum and amniotic fluid activin A levels.
Prenatal diagnosis 2004;24(7):574-5.
2004: Geralyn M Lambert-Messerlian; Jacquelyn Halliday; Josephine Williams; Rachel Cain; Michael E Msall; Glenn E Palomaki; Jacob A Canick
Effect of folic acid fortification on prevalence of neural tube defects in Rhode Island.
Journal of medical screening 2004;11(2):106-7.
2003: Jacob A Canick; Devereux N Saller; Geralyn M Lambert-Messerlian
Prenatal screening for Down syndrome: current and future methods.
Clinics in laboratory medicine 2003;23(2):395-411.
2003: Jacob A Canick; Leonard H Kellner; Allan T Bombard
Prenatal screening for open neural tube defects.
Clinics in laboratory medicine 2003;23(2):385-94, ix.
2003: Michael P Plevyak; Geralyn M Lambert-Messerlian; Antonio Farina; nigel P groome; Jacob A Canick; Helayne Silver
Concentrations of serum total activin A and inhibin A in preterm and term labor patients: a cross-sectional study.
Journal of the Society for Gynecologic Investigation 2003;10(4):231-6.
2003: Antonio Farina; Erik S LeShane; Geralyn M Lambert-Messerlian; Jacob A Canick; Thomas Lee; Louis M Neveux; Glenn E Palomaki; Diana Bianchi
Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy.
Clinical chemistry 2003;49(2):239-42.
2003: Tuangsit Wataganara; Erik S LeShane; Antonio Farina; Geralyn M Messerlian; Thomas Lee; Jacob A Canick; Diana Bianchi
Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18.
Human genetics 2003;112(2):204-8.
2003: Jacob A Canick
Safety first: choices in antenatal screening for Down's syndrome.
Journal of medical screening 2003;10(2):55.
2002: Geralyn M Messerlian; Jacob A Canick
Recent advances in maternal serum screening for Down syndrome.
Medicine and health, Rhode Island 2002;85(12):362-5.
2002: PP Thirunavukarasu; Geralyn M Lambert-Messerlian; David M Robertson; G Dawson; Jacob A Canick; Euan Wallace
Molecular weight forms of inhibin A, inhibin B and pro-alphaC in maternal serum, amniotic fluid and placental extracts of normal and Down syndrome pregnancies.
Prenatal diagnosis 2002;22(12):1086-92.
2002: Thomas Lee; Erik S LeShane; Geralyn M Messerlian; Jacob A Canick; Antonio Farina; Walter W Heber; Diana Bianchi
Down syndrome and cell-free fetal DNA in archived maternal serum.
American journal of obstetrics and gynecology 2002;187(5):1217-21.
2002: Helayne Silver; Geralyn M Lambert-Messerlian; Fernando M Reis; Anna Maria Diblasio; Felice Petraglia; Jacob A Canick
Mechanism of increased maternal serum total activin a and inhibin a in preeclampsia.
Journal of the Society for Gynecologic Investigation 2002;9(5):308-12.
2001: Marshall W Carpenter; Jacob A Canick; Joseph W Hogan; C Shellum; M Somers; JA Star
Amniotic fluid insulin at 14-20 weeks' gestation: association with later maternal glucose intolerance and birth macrosomia.
Diabetes care 2001;24(7):1259-63.
2001: I Yasuhi; Joseph W Hogan; Jacob A Canick; M B Sosa; Marshall W Carpenter
Midpregnancy serum C-peptide concentration and subsequent pregnancy-induced hypertension.
Diabetes care 2001;24(4):743-7.
2000: K M Goodwin; P J Sweeney; Geralyn M Lambert-Messerlian; Jacob A Canick
High maternal serum inhibin A levels following the loss of one fetus in a twin pregnancy.
Prenatal diagnosis 2000;20(12):1015-7.
2000: D N Rausch; Geralyn M Lambert-Messerlian; Jacob A Canick
Participation in maternal serum screening for Down syndrome, neural tube defects, and trisomy 18 following screen-positive results in a previous pregnancy.
The Western journal of medicine 2000;173(3):180-3.
2000: Geralyn M Lambert-Messerlian; Glenn E Palomaki; Jacob A Canick
Second trimester levels of maternal serum inhibin A in pregnancies affected by fetal neural tube defects.
Prenatal diagnosis 2000;20(8):680-2.
2000: Geralyn M Lambert-Messerlian; Helayne Silver; Felice Petraglia; S Luisi; I Pezzani; W M Maybruck; W A Hogge; K Hanley-Yanez; J M Roberts; Louis M Neveux; Jacob A Canick
Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy.
Journal of the Society for Gynecologic Investigation 2000;7(3):170-4.
2000: Fergal D Malone; Richard L Berkowitz; Jacob A Canick; Mary E D'alton
First-trimester screening for aneuploidy: research or standard of care?
American journal of obstetrics and gynecology 2000;182(3):490-6.
2000: M G Phipps; Joseph W Hogan; J F Peipert; Geralyn M Lambert-Messerlian; Jacob A Canick; David B Seifer
Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies.
Obstetrics and gynecology 2000;95(2):227-31.
2000: D N Rausch; Geralyn M Lambert-Messerlian; Jacob A Canick
Participation in maternal serum screening following screen positive results in a previous pregnancy.
Journal of medical screening 2000;7(1):4-6.
1999: Marshall W Carpenter; Jacob A Canick; JA Star; C Shellum; M Somers
A high-sensitivity assay for amniotic fluid insulin at 14-20 weeks' gestation.
Obstetrics and gynecology 1999;94(5 Pt 1):778-82.
1999: Jacob A Canick; Leonard H Kellner
First trimester screening for aneuploidy: serum biochemical markers.
Seminars in perinatology 1999;23(5):359-68.
1999: Howard Cuckle; Jacob A Canick; Leonard H Kellner
Collaborative study of maternal urine beta -core human chorionic gonadotrophin screening for Down syndrome.
Prenatal diagnosis 1999;19(10):911-7.
1999: Devereux N Saller; Jacob A Canick; Miriam G Blitzer; Glenn E Palomaki; Stuart Schwartz; Karin J Blakemore; J E Haddow
Second-trimester maternal serum analyte levels associated with fetal trisomy 13.
Prenatal diagnosis 1999;19(9):813-6.
1999: Geralyn M Lambert-Messerlian; Devereux N Saller; MB Tumber; CA French; C J Peterson; Jacob A Canick
Second-trimester maternal serum progesterone levels in Turner syndrome with and without hydrops and in trisomy 18.
Prenatal diagnosis 1999;19(5):476-9.
1999: Helayne Silver; Geralyn M Lambert-Messerlian; JA Star; J Hogan; Jacob A Canick
Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies.
American journal of obstetrics and gynecology 1999;180(5):1131-7.
1999: Jacob A Canick; Leonard H Kellner; Laurence A Cole; Howard Cuckle
Urinary analyte screening: a noninvasive detection method for Down syndrome?
Molecular medicine today 1999;5(2):68-73.
1998: Geralyn M Lambert-Messerlian; Jacob A Canick
Endocrine analytes in multiple-marker screening.
Clinics in perinatology 1998;25(4):963-81, vii.
1998: Geralyn M Lambert-Messerlian; Devereux N Saller; MB Tumber; CA French; C J Peterson; Jacob A Canick
Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops.
Prenatal diagnosis 1998;18(10):1061-7.
1998: Jacob A Canick; Stephen R Carr
Screening for birth defects: integrating laboratory evaluation, genetic counseling and clinical intervention.
Medicine and health, Rhode Island 1998;81(4):122-6.
1998: Geralyn M Lambert-Messerlian; S Luisi; P Florio; V Mazza; Jacob A Canick; Felice Petraglia
Second trimester levels of maternal serum total activin A and placental inhibin/activin alpha and betaA subunit messenger ribonucleic acids in Down syndrome pregnancy.
European journal of endocrinology / European Federation of Endocrine Societies 1998;138(4):425-9.
1998: Geralyn M Lambert-Messerlian; Jacob A Canick; DN Melegos; Eleftherios P Diamandis
Increased concentrations of prostate-specific antigen in maternal serum from pregnancies affected by fetal Down syndrome.
Clinical chemistry 1998;44(2):205-8.
1997: Leonard H Kellner; Jacob A Canick; Glenn E Palomaki; Louis M Neveux; Devereux N Saller; R P Walker; R Osathanondh; Allan T Bombard
Levels of urinary beta-core fragment, total oestriol, and the ratio of the two in second-trimester screening for Down syndrome.
Prenatal diagnosis 1997;17(12):1135-41.
1997: Devereux N Saller; Jacob A Canick; Leonard H Kellner; N C Rose; J Garza; CA French; Robert A Mooney
Maternal serum analyte levels in pregnancies with fetal Down syndrome resulting from translocations.
American journal of obstetrics and gynecology 1997;177(4):879-81.
1997: Laurence A Cole; Leonard H Kellner; T Isozaki; Glenn E Palomaki; Ray Kruse Iles; R P Walker; M Ozaki; Jacob A Canick
Comparison of 12 assays for detecting hCG and related molecules in urine samples from Down syndrome pregnancies.
Prenatal diagnosis 1997;17(7):607-14.
1997: Gary N Frishman; Jacob A Canick; Joseph W Hogan; Rick Hackett; Leonard H Kellner; Devereux N Saller
Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies.
Obstetrics and gynecology 1997;90(1):98-101.
1997: Geralyn M Lambert-Messerlian; Margaret Steinhoff; W Zheng; Jacob A Canick; Walter Gajewski; David B Seifer; Alan L Schneyer
Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer.
Gynecologic oncology 1997;65(3):512-6.
1997: JA Star; Jacob A Canick; Glenn E Palomaki; Marshall W Carpenter; Devereux N Saller; C James Sung; MB Tumber; DR Coustan
The relationship between second-trimester amniotic fluid insulin and glucose levels and subsequent gestational diabetes.
Prenatal diagnosis 1997;17(2):149-54.
1996: Laurence Cole; T Isozaki; Glenn E Palomaki; Jacob A Canick; Ray Kruse Iles; Leonard H Kellner; D Saller; Howard Cuckle
Detection of beta-core fragment in second trimester Down's syndrome pregnancies.
Early human development 1996;47 Suppl():S47-8.
1996: Howard Cuckle; Jacob A Canick; Leonard H Kellner; jan van lith; I White; B R Helbig; NC Rose; IK Sehmi; R Jones
Urinary beta-core-hCG screening in the first trimester.
Prenatal diagnosis 1996;16(11):1057-9.
1996: R V Haning; Umadevi Tantravahi; Q Zhao; Rick Hackett; Jacob A Canick
5alpha-reductase 1 and 2 expression and activity in human ovarian follicles, stroma and corpus luteum as compared to neonatal foreskin.
The Journal of steroid biochemistry and molecular biology 1996;59(2):199-204.
1996: Devereux N Saller; Jacob A Canick; C E Oyer
The detection of non-immune hydrops through second-trimester maternal serum screening.
Prenatal diagnosis 1996;16(5):431-5.
1996: David B Seifer; Geralyn M Lambert-Messerlian; Jacob A Canick; Gary N Frishman; Alan L Schneyer
Serum inhibin levels are lower in ectopic than intrauterine spontaneously conceived pregnancies.
Fertility and sterility 1996;65(3):667-9.
1996: Devereux N Saller; C E Oyer; JA Star; Jacob A Canick
A normative study of obstetric complications associated with fetal trisomy 18.
Journal of perinatology : official journal of the California Perinatal Association 1996;16(2 Pt 1):117-20; quiz 121-2.
1996: Geralyn M Lambert-Messerlian; Jacob A Canick; Glenn E Palomaki
Maternal serum total activin A in pregnancies affected with fetal Down's syndrome.
Journal of medical screening 1996;3(4):217.
1996: Geralyn M Lambert-Messerlian; Jacob A Canick; Glenn E Palomaki; Alan L Schneyer
Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy.
Journal of medical screening 1996;3(2):58-62.
1996: R V Haning; Jacob A Canick; L T Goldsmith; K A Shahinian; N J Erinakes; Gerson Weiss
The effect of ovulation induction on the concentration of maternal serum relaxin in twin pregnancies.
American journal of obstetrics and gynecology 1996;174(1 Pt 1):227-32.
1996: Marshall W Carpenter; Jacob A Canick; JA Star; Stephen R Carr; M E Burke; K Shahinian
Fetal hyperinsulinism at 14-20 weeks and subsequent gestational diabetes.
Obstetrics and gynecology 1996;87(1):89-93.
1995: Jacob A Canick; Leonard H Kellner; Devereux N Saller; Glenn E Palomaki; R P Walker; R Osathanondh
Second-trimester levels of maternal urinary gonadotropin peptide in Down syndrome pregnancy.
Prenatal diagnosis 1995;15(8):739-44.
1995: Glenn E Palomaki; James E Haddow; George J Knight; Nicholas J Wald; A Kennard; Jacob A Canick; Devereux N Saller; Miriam G Blitzer; L H Dickerman; R Fisher
Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin.
Prenatal diagnosis 1995;15(8):713-23.
1994: Devereux N Saller; Jacob A Canick; G E Palomaki; George J Knight; J E Haddow
Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defects.
Obstetrics and gynecology 1994;84(5):852-5.
1994: NC Rose; Jacob A Canick; George J Knight; A Pulkkinen; MB Tumber; Michael T Mennuti; Glenn E Palomaki
Second-trimester diurnal variation of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol: is it present and does it affect the prediction of a patient's risk for fetal Down syndrome?
Prenatal diagnosis 1994;14(10):947-51.
1993: R Neiger; C Wise; S A Contag; MB Tumber; Jacob A Canick
First trimester bleeding and pregnancy outcome in gravidas with normal and low folate levels.
American journal of perinatology 1993;10(6):460-2.
1993: Devereux N Saller; Beverly B Rogers; Jacob A Canick
Maternal serum biochemical markers in pregnancies with fetal parvovirus B19 infection.
Prenatal diagnosis 1993;13(6):467-71.
1993: Devereux N Saller; J V Dailey; D L Doyle; Stephen R Carr; Jacob A Canick; Beverly B Rogers
Turner syndrome associated with an omphalocele.
Prenatal diagnosis 1993;13(5):424-6.
1993: Glenn E Palomaki; George J Knight; James E Haddow; Jacob A Canick; Nicholas J Wald; A Kennard
Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening.
Obstetrics and gynecology 1993;81(5 ( Pt 1)):675-8.
1992: Glenn E Palomaki; George J Knight; James E Haddow; Jacob A Canick; Devereux N Saller; D S Panizza
Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin.
Prenatal diagnosis 1992;12(11):925-30.
1992: Devereux N Saller; Jacob A Canick; Stuart Schwartz; Miriam G Blitzer
Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndrome.
American journal of obstetrics and gynecology 1992;167(4 Pt 1):1021-4.
1992: James E Haddow; Glenn E Palomaki; George J Knight; J Williams; A Pulkkinen; Jacob A Canick; Devereux N Saller; G B Bowers
Prenatal screening for Down's syndrome with use of maternal serum markers.
The New England journal of medicine 1992;327(9):588-93.
1992: C E Oyer; Jacob A Canick
Maternal serum hCG levels in triploidy: variability and need to consider molar tissue.
Prenatal diagnosis 1992;12(7):627-9.
1992: R V Haning; Rick Hackett; Jacob A Canick
Steroid sulfatase in the human ovary and placenta: enzyme kinetics and phosphate inhibition.
The Journal of steroid biochemistry and molecular biology 1992;41(2):161-5.
1990: Jacob A Canick; G J Knight; Glenn E Palomaki; J E Haddow
Second-trimester levels of maternal serum unconjugated oestriol and human chorionic gonadotropin in pregnancies affected by fetal anencephaly and open spina bifida.
Prenatal diagnosis 1990;10(11):733-7.
1990: Jacob A Canick; Glenn E Palomaki; R Osathanondh
Prenatal screening for trisomy 18 in the second trimester.
Prenatal diagnosis 1990;10(8):546-8.
1990: R V Haning; Rick Hackett; R I Boothroid; Jacob A Canick
Steroid sulphatase activity in the human ovarian corpus luteum, stroma, and follicle: comparison to activity in other tissues and the placenta.
Journal of steroid biochemistry 1990;36(1-2):175-9.
1988: Jacob A Canick; G J Knight; Glenn E Palomaki; J E Haddow; Howard Cuckle; Nicholas J Wald
Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome.
British journal of obstetrics and gynaecology 1988;95(4):330-3.
1987: Jacob A Canick; Stuart A Tobet; Michael J Baum; D E Vaccaro; K J Ryan; S E Leeman; T O Fox
Studies on the role of catecholamines in the regulation of the developmental pattern of hypothalamic aromatase.
Steroids 1987;50(4-6):509-21.
1986: Jacob A Canick; D E Vaccaro; E M Livingston; S E Leeman; K J Ryan; T O Fox
Localization of aromatase and 5 alpha-reductase to neuronal and non-neuronal cells in the fetal rat hypothalamus.
Brain research 1986;372(2):277-82.